John Lövrot
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Breast Cancer Treatment Studies 10
- Cancer, Hypoxia, and Metabolism 1
- Cancer Genomics and Diagnostics 1
- Oncology 8
- Cancer Cells and Metastasis 6
- Co-authors
- Jonas C. S. Bergh (15 shared papers)Michael Bartoschek (2 shared papers)Kristian Pietras (2 shared papers)Matteo Bocci (2 shared papers)Christer Larsson (2 shared papers)Göran Karlsson (1 shared paper)Theodoros Foukakis (9 shared papers)Nikolay Oskolkov (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)Clinical Cancer Research (2 papers)Annals of Oncology (2 papers)Journal of Clinical Investigation (1 paper)BMC Cancer (1 paper)
- Partner nations
- SwedenUnited StatesBelgium
In The Last Decade
John Lövrot
19 papers receiving 1.8k citations
John Lövrot's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 849
- Cancer Research 476
- Immunology 210
- Molecular Biology 518
- Pulmonary and Respiratory Medicine 139
Countries citing papers authored by John Lövrot
This map shows the geographic impact of John Lövrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lövrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lövrot more than expected).
Fields of papers citing papers by John Lövrot
This network shows the impact of papers produced by John Lövrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lövrot. The network helps show where John Lövrot may publish in the future.
Co-authors
The 25 scholars most cited alongside John Lövrot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing Hit paper breakdown → | 2018 | 661 |
| 2 | An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression Hit paper breakdown → | 2017 | 443 |
| 3 | 2018 | 123 | |
| 4 | 2019 | 97 | |
| 5 | 2019 | 80 | |
| 6 | 2014 | 78 | |
| 7 | 2017 | 68 | |
| 8 | 2015 | 51 | |
| 9 | 2018 | 50 | |
| 10 | 2015 | 46 | |
| 11 | 2018 | 42 | |
| 12 | 2018 | 40 | |
| 13 | 2020 | 14 | |
| 14 | 2022 | 14 | |
| 15 | 2015 | 13 | |
| 16 | 2017 | 12 | |
| 17 | 2018 | 11 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 1 |
About John Lövrot
John Lövrot is a scholar working on Cancer Research, Oncology, Pharmacology, Molecular Biology and Genetics, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Cancer Cells and Metastasis (6 papers), Cancer, Hypoxia, and Metabolism (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), TGF-β signaling in diseases (1 paper), Cancer Genomics and Diagnostics (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Oncology (849 citations), Cancer Research (476 citations), Immunology (210 citations), Molecular Biology (518 citations) and Pulmonary and Respiratory Medicine (139 citations). John Lövrot has collaborated with scholars based in Sweden, United States and Belgium. Frequent co-authors include Jonas C. S. Bergh, Michael Bartoschek, Kristian Pietras, Matteo Bocci, Christer Larsson, Göran Karlsson, Theodoros Foukakis, Nikolay Oskolkov, Mikael N.E. Sommarin and Åsa K. Björklund. Their work appears in journals such as British Journal of Cancer, Clinical Cancer Research, Annals of Oncology, Journal of Clinical Investigation and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.